JP2014529613A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014529613A5 JP2014529613A5 JP2014527357A JP2014527357A JP2014529613A5 JP 2014529613 A5 JP2014529613 A5 JP 2014529613A5 JP 2014527357 A JP2014527357 A JP 2014527357A JP 2014527357 A JP2014527357 A JP 2014527357A JP 2014529613 A5 JP2014529613 A5 JP 2014529613A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- seq
- haloalkyl
- amyloid beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161527584P | 2011-08-25 | 2011-08-25 | |
| US61/527,584 | 2011-08-25 | ||
| US201161527963P | 2011-08-26 | 2011-08-26 | |
| US61/527,963 | 2011-08-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014529613A JP2014529613A (ja) | 2014-11-13 |
| JP2014529613A5 true JP2014529613A5 (https=) | 2016-03-31 |
Family
ID=47747106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014527357A Pending JP2014529613A (ja) | 2011-08-25 | 2012-08-27 | 神経変性疾患を治療する組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140378460A1 (https=) |
| EP (1) | EP2747768A4 (https=) |
| JP (1) | JP2014529613A (https=) |
| CN (2) | CN104053436A (https=) |
| AU (2) | AU2012298617B2 (https=) |
| BR (1) | BR112014004416A2 (https=) |
| CA (1) | CA2846611A1 (https=) |
| HK (1) | HK1202246A1 (https=) |
| IL (1) | IL231158A0 (https=) |
| RU (1) | RU2014111078A (https=) |
| WO (1) | WO2013029060A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2747759A4 (en) * | 2011-08-25 | 2015-05-13 | Cognition Therapeutics Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| PL3062791T3 (pl) | 2013-10-28 | 2020-06-15 | Drexel University | Nowoczesne terapie zaburzeń uwagi i zaburzeń poznawczych oraz otępienia związanych z zaburzeniem neurodegeneracyjnym |
| RU2692258C2 (ru) | 2014-01-31 | 2019-06-24 | Когнишн Терапьютикс, Инк. | Композиции изоиндолина и способы лечения нейродегенеративного заболевания |
| WO2016178852A1 (en) * | 2015-05-04 | 2016-11-10 | The Trustees Of The University Of Pennsylvania | 211-astatine containing radiotherapeutics for the treatment of cancer |
| HK1247847A1 (zh) | 2015-07-22 | 2018-10-05 | 阿纳韦克斯生命科学公司 | 四氢-N，N-二甲基-2，2-二苯基-3-呋喃甲胺的对映体(ANAVEX2-73)及其在治疗阿尔海默氏病和其他由σ1受体调节的疾病中的用途 |
| CA3058782A1 (en) * | 2017-04-03 | 2018-10-11 | The Regents Of The University Of California | Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery |
| CN106986836A (zh) * | 2017-04-26 | 2017-07-28 | 毛阿龙 | 具有抗细菌活性的新型速激肽拮抗剂的制备方法 |
| DK3634394T3 (da) | 2017-05-15 | 2026-03-02 | Cognition Therapeutics Inc | Sammensætninger til behandling af neurogenerative sygdomme |
| US12352719B2 (en) | 2019-09-20 | 2025-07-08 | KYCERA AVX Components Corporation | Somatic cell-based electrical biosensor |
| WO2021064610A1 (en) * | 2019-10-01 | 2021-04-08 | Ac Immune Sa | Micro-radiobinding assays for ligand screening |
| IL303592A (en) * | 2020-12-11 | 2023-08-01 | Cognition Therapeutics Inc | Compositions for treating dry age-related macular degeneration (amd) |
| CN112816533A (zh) * | 2020-12-31 | 2021-05-18 | 商丘师范学院 | 一种铜纳米簇作为电化学信号探针的β-淀粉样蛋白寡聚体传感器 |
| WO2026030341A1 (en) | 2024-07-29 | 2026-02-05 | Cognition Therapeutics, Inc. | Zervimesine for treating neurodegenerative disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997030038A1 (en) * | 1996-02-15 | 1997-08-21 | Mitsubishi Chemical Corporation | Diarylsultam derivatives |
| EP1644026A4 (en) * | 2003-06-12 | 2007-10-24 | Ms Science Corp | SIGMA LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RECREATION |
| WO2006027252A1 (en) * | 2004-09-10 | 2006-03-16 | Ucb Pharma, Sa | Sigma receptor ligands |
| ITRM20060007A1 (it) * | 2006-01-05 | 2007-07-06 | Univ Bari | Recettore sigma-2 metodo di screening di ligandi specifici e uso degli stessi in metodi diagnostici o terapeutici |
| WO2007112288A2 (en) * | 2006-03-23 | 2007-10-04 | Mount Sinai School Of Medicine | Cardiovascular composition and use the same for the treatment of alzheimers disease |
| WO2010088450A2 (en) * | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
| ES2545795T3 (es) * | 2009-04-09 | 2015-09-15 | Cognition Therapeutics, Inc. | Inhibidores del deterioro cognitivo |
| CN102595884B (zh) * | 2009-07-31 | 2014-12-03 | 考格尼申治疗股份有限公司 | 认知衰退的抑制剂 |
| WO2011106785A2 (en) * | 2010-02-26 | 2011-09-01 | Cognition Therapeutics, Inc. | Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
-
2012
- 2012-08-27 EP EP12825341.6A patent/EP2747768A4/en not_active Withdrawn
- 2012-08-27 HK HK15102753.6A patent/HK1202246A1/xx unknown
- 2012-08-27 AU AU2012298617A patent/AU2012298617B2/en not_active Ceased
- 2012-08-27 CA CA2846611A patent/CA2846611A1/en not_active Abandoned
- 2012-08-27 WO PCT/US2012/052578 patent/WO2013029060A2/en not_active Ceased
- 2012-08-27 CN CN201280052588.4A patent/CN104053436A/zh active Pending
- 2012-08-27 BR BR112014004416A patent/BR112014004416A2/pt not_active IP Right Cessation
- 2012-08-27 RU RU2014111078/15A patent/RU2014111078A/ru not_active Application Discontinuation
- 2012-08-27 US US14/241,026 patent/US20140378460A1/en not_active Abandoned
- 2012-08-27 CN CN201710491989.4A patent/CN107260726A/zh active Pending
- 2012-08-27 JP JP2014527357A patent/JP2014529613A/ja active Pending
-
2014
- 2014-02-25 IL IL231158A patent/IL231158A0/en unknown
-
2016
- 2016-06-30 AU AU2016204554A patent/AU2016204554A1/en not_active Abandoned
-
2017
- 2017-04-21 US US15/493,979 patent/US20170349554A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014529613A5 (https=) | ||
| ES2649155T3 (es) | Anticuerpos anti-OX40 y procedimientos de uso de los mismos | |
| Fang et al. | Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response | |
| JP2019059786A5 (https=) | ||
| JP2014524482A5 (https=) | ||
| Robson et al. | SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation | |
| ES2865023T3 (es) | Anticuerpo anti-lipoarabinomanano e inmunoensayo para detectar la infección por bacilos acidorresistentes usando el anticuerpo | |
| JP2014508748A5 (https=) | ||
| CN105050621B (zh) | 防止和治疗多发性硬化症的方法 | |
| Wiesner et al. | Reversible induction of TDP-43 granules in cortical neurons after traumatic injury | |
| SA515360253B1 (ar) | أجسام مضادة مُميزة لألفا سينوكلين | |
| RU2013141134A (ru) | Антитела, которые специфично связывают альфа-токсин staphylococcus aureus, и способы их применения | |
| CN103429260B (zh) | 用于治疗神经疾病的人抗体及其诊断和治疗用途 | |
| RU2017105515A (ru) | Сигнальная система | |
| HRP20140240T4 (hr) | Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba | |
| RU2014111078A (ru) | Композиции и способы для лечения нейродегенеративного заболевания | |
| JP2013506425A5 (https=) | ||
| CN105979962A (zh) | 使用抗Aβ抗体减少脑淀粉样蛋白斑块的方法 | |
| JP2016509585A5 (https=) | ||
| TR201903026T4 (en) | S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES. | |
| CN104379167B (zh) | 用于中风和缺血或缺血性病况的人抗体及其特异性结合序列 | |
| JP2017511377A5 (https=) | ||
| CN101374514A (zh) | 神经元烟碱性受体配体和它们的用途 | |
| Cheng et al. | The glomerulus–a view from the outside–the podocyte | |
| Ciprés-Flores et al. | Beta-blockers and salbutamol limited emotional memory disturbance and damage induced by orchiectomy in the rat hippocampus |